Drug Type Small molecule drug |
Synonyms 9-cis-9-demethyl-retinal |
Target |
Action agonists |
Mechanism RXRs agonists(Retinoid X receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Retinitis Pigmentosa | Preclinical | United States | 18 Nov 2025 |





